Edition:
India

FibroGen Inc (FGEN.OQ)

FGEN.OQ on NASDAQ Stock Exchange Global Select Market

54.60USD
20 Feb 2018
Change (% chg)

$-1.90 (-3.36%)
Prev Close
$56.50
Open
$55.95
Day's High
$57.00
Day's Low
$54.40
Volume
321,527
Avg. Vol
196,915
52-wk High
$63.00
52-wk Low
$22.80

Select another date:

Thu, Nov 9 2017

BRIEF-Fibrogen Inc reports Q3 loss per share $0.50

* Q3 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S

BRIEF-Fibrogen announces acceptance by china FDA of roxadustat NDA for treatment of anemia associated with dialysis and non-dialysis kidney disease

* Fibrogen announces acceptance by china FDA of roxadustat new drug application (NDA) for treatment of anemia associated with dialysis and non-dialysis chronic kidney disease (CKD)

BRIEF-Fibrogen's ‍Pamrevlumab was well tolerated with no safety risks

* ‍Announced results from co's phase 2b randomized, double-blind, placebo-controlled study in patients with idiopathic pulmonary fibrosis​

Select another date: